Price Wealth’s Celgene Corp CELG Stock Holding History

Price Wealth’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-409	Closed	-$32K	–	480
2018 Q2	$32K	Buy	409 +236	+136%	+$19.6K	0.01%	151
2018 Q1	$15K	Sell	173 -173	-50%	-$16.6K	0.01%	128
2017 Q4	$36K	Buy	+346	New	+$39K	0.02%	72

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Price Wealth's CELG Position: Q3 2018 in Review

Price Wealth sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 409 shares — an estimated $32K sold.

Price Wealth first reported a position in CELG in Q4 2017 and held it in 3 quarters. The position peaked at $36K in Q4 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

Price Wealth reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
Price Wealth sold 409 Celgene Corp shares in Q3 2018, an estimated $32K.
Price Wealth first reported a position in Celgene Corp in Q4 2017 and held it in 3 quarters.
Price Wealth's Celgene Corp position peaked at $36K in Q4 2017.
1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Price Wealth's 13F filing for Q3 2018, filed 2 Nov 2018.